Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapies for inhibition of polo-like kinase 4

Combination therapies for inhibition of polo-like kinase 4

US Patent 12109215 · Granted Oct 8, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

LILRB3-binding molecules and uses therefor2025
LILRB3-binding molecules and uses therefor2025
Crystal form S4 of the PLK4 inhibitor (1R,2S)-(e)-2-(3-(4-((cis-2,6-dimethylmorp2025
FCMR-binding molecules and uses thereof2025
FCMR-binding molecules and uses thereof2025
Combination therapies for inhibition of TTK protein kinase2023
Combination therapies for inhibition of TTK protein kinase2023
Combination therapies for inhibition of TTK protein kinase2023
Combination therapies for inhibition of TTK protein kinase2023
RIPK2 inhibitors and method of treating cancer with same2020
RIPK2 inhibitors and method of treating cancer with same2020
Methods and compositions for modulating toso activity2020